SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (867)11/17/1998 10:20:00 AM
From: Sector Investor  Read Replies (1) of 887
 
"The terms of the contingent payment provide that DepoTech shareholders will receive approximately 1.5 million additional SkyePharma ADS's if DepoTech's lead product, DepoCyt(TM), an anticancer drug, is launched in the U.S. no later than March 31, 2000. Further, DepoTech shareholders will receive approximately 1.2 million
additional SkyePharma ADS's if a development agreement is signed with a corporate partner for either DepoMorphine(TM) or a macromolecule program."

Apparently approval is not the same as launching in the U.S, as the additional shares don't appear to be factored in? Or am I reading it wrong? Is there a play here based on this?

Oops, it looks like the price is moving up.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News